Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2008;94:692-694; doi:10.1136/hrt.2007.126326
Copyright © 2008 BMJ Publishing Group Ltd & British Cardiovascular Society

EDITORIALS

Time to rethink high-density lipoprotein?

Sarah Wild1, Christopher D Byrne2

1 Public Health Sciences, University of Edinburgh, Teviot Place, Edinburgh, UK
2 Southampton General Hospital, Southampton, UK

Correspondence to:
Professor C D Byrne, Department of Endocrinology and Metabolism, Mail Point 113, Level F, Centre Block, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK; C.D.Byrne@soton.ac.uk

The first 150 words of the full text of this article appear below.

Decreasing low-density lipoprotein cholesterol (LDL-C) concentrations with statin treatment represents a key therapeutic strategy for primary and secondary prevention of cardiovascular disease, as summarised in the Joint British Societies 2 guidelines.1 However, the relative risk reduction for major vascular events for each mmol/l reduction in LDL-C associated with use of statins is only approximately 20%2 and many people treated with statins will go on to have their first or subsequent cardiovascular disease event. Consequently, there is a pressing need to develop alternative strategies to decrease risk of vascular disease.

A wealth of epidemiological observational data suggests there is a strong inverse causal relation between concentrations of high-density lipoprotein cholesterol (HDL-C) and risk of cardiovascular disease. For example, a review of four large prospective studies suggests that every increase of 0.03 mmol/l in HDL-C is associated with a 2–3% decreased risk of cardiovascular disease.3 This suggests that raising HDL-C could be . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels
D J Hausenloy and D M Yellon
Heart 2008 94: 706-714. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.